Lymphocyte respiration in children with Trisomy 21

BMC Pediatrics

Abdul-Kader Souid¹  Elhadi H Aburawi¹ 

[1]Department of Pediatrics, UAE University, P.O. Box 17666, Al Ain, United Arab Emirates

关键词: Hypothyroidism;    Trisomy 21;    Mitochondria;    Respiration;    Oxygen;   

Others  :  1170593
DOI  :  10.1186/1471-2431-12-193

 received in 2012-05-10, accepted in 2012-12-12,  发布年份 2012

【 摘 要 】

Background

This study measured lymphocyte mitochondrial O₂ consumption (cellular respiration) in children with trisomy 21.

Methods

Peripheral blood mononuclear cells were isolated from whole blood of trisomy 21 and control children and these cells were immediately used to measure cellular respiration rate. [O₂] was determined as a function of time from the phosphorescence decay rates (1/τ) of Pd (II)-meso-tetra-(4-sulfonatophenyl)-tetrabenzoporphyrin. In sealed vials containing lymphocytes and glucose as a respiratory substrate, [O₂] declined linearly with time, confirming the zero-order kinetics of O₂ conversion to H₂O by cytochrome oxidase. The rate of respiration (k, in μM O₂ min^-1), thus, was the negative of the slope of [O₂] vs. time. Cyanide inhibited O₂ consumption, confirming that oxidation occurred in the mitochondrial respiratory chain.

Results

For control children (age = 8.8 ± 5.6 years, n = 26), the mean (± SD) value of k_c (in μM O₂ per min per 10⁷ cells) was 1.36 ± 0.79 (coefficient of variation, Cv = 58%; median = 1.17; range = 0.60 to 3.12; -2SD = 0.61). For children with trisomy 21 (age = 7.2 ± 4.6 years, n = 26), the values of k_c were 0.82 ± 0.62 (Cv = 76%; median = 0.60; range = 0.20 to 2.80), p<0.001. Similar results (p<0.000) were obtained after excluding the five trisomy 21 children with elevated serum TSH (values >6.1 mU/L). Fourteen of 26 (54%) children with trisomy 21 had k_c values of 0.20 to 0.60 (i.e., <−2SD). The values of k_c positively correlated with body-mass index (BMI, R >0.302), serum creatinine(R >0.507), blood urea nitrogen (BUN, R >0.535) and albumin (R >0.446).

Conclusions

Children with trisomy 21 in this study have reduced lymphocyte bioenergetics. The clinical importance of this finding requires further studies.

【 授权许可】

   
2012 Aburawi and Souid; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA, Collins JS, Kirby RS, Correa A: Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006 birth defects. Res A Clin Mol Teratol 2010, 88:100-1016.
• [2]Luke A, Roizen NJ, Sutton M, Shoeller DA: Energy expenditure in children with Down syndrome: Correcting metabolic rate for movement. J Pediatr 1994, 125:829-838.
• [3]Doglus S: Down syndrome: Immunologic and Epidemiologic association-Enigmas remain. J Pediatr 2005, 147:724-725.
• [4]Murdoch JC, Ratcliffe WA, McLarty DG, Rodger JC, Ratcliffe JG: Thyroid function in adults with Down's syndrome. J Clin Endocrinol Metab 1977, 44:453-458.
• [5]Abu Faddan N, Sayed D, Ghaleb F: T-lymphocytes apoptosis and mitochondrial membrane potential in Down's syndrome. Fetal and Pediatric Pathology 2011, 30:45-52.
• [6]Baracca A, Sgarbi G, Solaini G, Lenaz G: Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F0 during ATP synthesis. Biochim Biophys Acta 2003, 1606:137-146.
• [7]Kirkinezos IG, Moraes CT: Reactive oxygen species and mitochondrial diseases. Seminars in Cell & Developmental Biology 2001, 12:449-457.
• [8]Sureda FX, Escubedo E, Gabriel C, Comas J, Camarasa J, Camins A: Mitochondrial membrane potential measurement in rat cerebellar neurons by flow cytometry. Cytometry 1997, 28:74-80.
• [9]Prince J, Jia S, Båve U, Annerén G, Oreland L: Mitochondrial enzyme deficiencies in Down's syndrome. J Neural Transm Park Dis Dement Sect 1994, 8:171-181.
• [10]More R, Amir N, Meyer S, Kopolovic J, Yarom R: Platelet abnormalities in Down's syndrome. Clin Genet 1982, 22:128-136.
• [11]Al-Jasmi F, Penefsky HS, Souid A-K: The phosphorescence oxygen analyzer as a screening tool for disorders with impaired lymphocyte bioenergetics. Mol Genet Metab 2011, 104:529-536.
• [12]Shaban S, Marzouqi F, Al Mansouri A, Penefsky HS, Souid AK: Oxygen measurements via phosphorescence. Comput Methods Programs Biomed 2010, 100:265-268.
• [13]Souid AK, Tacka KA, Galvan KA, Penefsky HS: Immediate effects of anticancer drugs on mitochondrial oxygen consumption. Biochem Pharmacol 2003, 66:977-987.
• [14]Lo L-W, Koch CJ, Wilson DF: Calibration of oxygen-dependent quenching of the phosphorescence of Pd-meso-tetra (4-carboxyphenyl) porphine: A phosphor with general application for measuring oxygen concentration in biological systems. Anal Biochem 1996, 236:153-160.
• [15]Solini A, Bonora E, Bonadonna R, Castellino P, DeFronzo RA: Protein metabolism in human obesity: relationship with glucose and lipid metabolism and with visceral adipose tissue. J Clin Endocrinol Metab 1997, 82:2552-2558.
• [16]Jensen MD, Haymond MW: Protein metabolism in obesity: effects of body fat distribution and hyperinsulinemia on leucine turnover. Am J Clin Nutr 1991, 5:172-176.
• [17]Lassen NA, Christensen S, Hoedt-Rasmussen K, Stewart BM: Cerebral oxygen consumption in Down's syndrome. Arch Neurol 1966, 15:595-602.
• [18]Garfunkel JM, Baird HW, Ziegler J: The relation of oxygen consumption to cerebral function activity. J Pediatr 1954, 44:64-72.
• [19]Pagano G, Castello G: Oxidative stress and mitochondrial dysfunction in Down syndrome. Adv Exp Med Bio 2012, 724:291-299.
• [20]Valenti D, Manente GA, Moro L, Marra E, Vacca RA: Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signaling pathway. Biochem J 2011, 435:679-688.
• [21]Infantino V, Castegna A, Iacobazzi F, Spera I, Scala I, Andria G, Iacobazzi V: Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down's syndrome. Mol Genet Metab 2011, 102:378-382.
• [22]Pallardó FV, Lloret A, Lebel M, d'Ischia M, Cogger VC, Le Couteur DG, Gadaleta MN, Castello G, Pagano G: Mitochondrial dysfunction in some oxidative stress-related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anemia and Werner Syndrome. Biogerontology 2010, 11:401-419.
• [23]Valenti D, Tullo A, Caratozzolo MF, Merafina RS, Scartezzini P, Marra E, Vacca RA: Impairment of F1F0-ATPase, adenine nucleotide translocator and adenylate kinase causes mitochondrial energy deficit in human skin fibroblasts with chromosome 21 trisomy. Biochem J 2010, 431:299-310.